![]() | Up a level |
Number of items: 1.
Pontes, Caridad, Zara, Corinne, Torrent-Farnell, Josep, Obach, Merce, Nadal, Cristina, Vella-Bonanno, Patricia, Ermisch, Michael, Simoens, Steven, Hauegen, Renata Curi, Gulbinovic, Jolanta et al (show 13 more authors)
(2020)
Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 18 (1).
pp. 5-16.